Biogen Discontinues Alzheimer’s Drug Aduhelm

Published on January 31, 2024

Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago.

Read Full Article (External Site)